On Wednesday, Shares of Aetna Inc (NYSE:AET), subtract -1.52% and closed at $110.37 in the last trading session. The last trading range of the stock ranges between $109.57 and $112.69. The company’s Market capitalization is $37.83 Billion with the total Outstanding Shares of 350.80 million. During the 52-week trading session the minimum price at which share price traded, registered at $92.42 and reached to max level of $123.57. Aetna (AET), one of the nation’s leading health care benefits companies, once again achieved high Medicare Star Quality Ratings for its Medicare Advantage Prescription Drug (MAPD) plans for 2017. Aetna has the highest percentage of Medicare members enrolled in plans rated 4.0 overall stars among publicly traded companies*.
“Aetna is extremely proud of our strong Medicare star ratings which, in an increasingly competitive industry, reflect our commitment to increasing the number of healthy days for our members,” said Nancy Cocozza, president of Aetna’s Medicare business. “We are focused on encouraging our members to work more closely with their doctors to enhance care coordination and patient satisfaction, and on improving our members’ overall health care experience.”
In the most recent star ratings from the Centers for Medicare & Medicaid Services (CMS), Aetna MAPD plans achieved an overall enrollment weighted average rating of 4.0 stars for 2017 star ratings. Aetna has increased the number of members enrolled in plans with a star rating of 4.0 or higher to 91 percent, representing a four-percentage point increase from last year.
Enterprise Products Partners L.P. (NYSE:EPD), dropped -0.15% and closed at $27.23 in the last trading session. The last trading range of the stock ranges between $26.94 and $27.26. The company’s Market capitalization is $56.68 Billion with the total Outstanding Shares of 2.09 billion. During the 52-week trading session the minimum price at which share price traded, registered at $19.00 and reached to max level of $30.10. Enterprise Products Partners L.P. (EPD) (“Enterprise”) declared recently that the board of directors of its general partner declared a boost in the quarterly cash distribution paid to partners to $0.405 per common unit, or $1.62 per unit on an annualized basis. This distribution is equal to the distribution that Enterprise’s administration had indicated in its press release dated January 4, 2016 that it would recommend to the board of Enterprise’s general partner with respect to the third quarter of 2016.
The quarterly distribution will be paid on Monday, November 7, 2016, to unitholders of record as of the close of business on Monday, October 31, 2016. This distribution, which represents a 5.2 percent increase over the distribution declared with respect to the third quarter of 2015, is the 58th distribution increase since Enterprise’s initial public offering in 1998 and the 49th successive quarterly increase.
MannKind Corporation (NASDAQ:MNKD), lost -1.00% and closed at $0.594 in the last trading session. The last trading range of the stock ranges between $0.58 and $0.61. During the 52-week trading session the minimum price at which share price traded, registered at $0.55 and reached to max level of $3.79. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. Its approved product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and partnershipagreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA.